Companies need to do a better job of warning about the risk of their products. Often, then don’t warn because it would hurt sales of the drug or device.
But warnings are not always as simple as plaintiffs’ lawyers make it out to me, either, as the Archives of Internal Medicine points out in a research letter published online.
This does not change my view that drug companies repeatedly and intentionally fail to properly warn doctors and patients about the risk. But there is a bit of nuance going on in some cases… that we sometimes try to ignore.